Medical diagnostics firm Alveo Technologies Inc reported on Thursday the election of Johnson Chiang, PhD as its chief technology officer and Rixun Fang, PhD as director of its Assay Development.

In the senior position in the company, Dr Chiang will lead and oversee the company's high-performance product development and commercialiation, with focus on ensuring the technology reaches its full potential, through US FDA approval and into the market.

Previously, Dr Chiang has served as head of Systems Integration and Molecular Biology at Foundation Medicine Inc, held senior management positions at Life Technologies and Thermo Fisher Scientific as well as led molecular diagnostic development projects at Applied MEMS, Applied Biosystems Inc and Cepheid.

Earlier in his career, Dr Fang has successfully led many projects from inception through development and implementation at Applied Biosystems, Life Technologies as well as Thermo Fisher Scientific.